A Multicenter, Prospective, Real-world Study of a Regimen Containing Tucidinostat for Primary Treatment of DLBCL
Clinical trial NCT06779435 · RECRUITING
Trial details
- NCT number
- NCT06779435
- Sponsor
- Ruijin Hospital
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-01-01
- Primary completion
- 2027-12-31
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.